Atlas Trials

The Safety and Effectiveness of Transcatheter Aortic Valve Raplacemet in Intermediate Risk Patients With Bicuspid Aortic Stenosis

Clinical trial NCT03163329 · UNKNOWN

Trial details

NCT number
NCT03163329
Sponsor
China National Center for Cardiovascular Diseases
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Aortic Valve Disease
Start date
2018-02-01
Primary completion
2020-10-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.